|Title:||Policy on Introduction of High-Cost Health Technologies|
|Document ID:||Operational Directive OD 0285/10|
|Date of issue:||Monday, 17 May 2010|
|Status:||NO LONGER APPLICABLE|
|Description:||This policy provides a state wide framework for the introduction of high-cost health technologies into clinical practice|
|Period of effect:||from 20 April 2010 to 20 April 2015|
|Review date:||20 April 2015|
|Authorised by:||Mr Kim Snowball, Acting Director General, Department of Health, 04-May-2010|
|Print version:||View print version|
Policy on Introduction of High-Cost Health Technologies
WA Health has a responsibility to maintain existing technology in services, to disinvest in any technologies that are deemed to deliver no or low health gains and to ensure that new technologies, where appropriate, are introduced into services. Technology is considered one of the most significant drivers of increased healthcare expenditure. Novel procedures, diagnostic and therapeutic devices need to be introduced into the health system with proper assessment of their utility, safety and cost. WA Health is one of a growing number of state and national health services considering better ways to define priorities that provide the greatest benefit within the available resources.
In 2007, the State Health Executive Forum (SHEF) endorsed the formation of a state advisory committee on technology known as the Western Australian Policy Advisory Committee on Technology (WAPACT). This endorsement recognises that the responsibility for technology adoption needs to take a ‘whole of health’ perspective and that a systematic and standardised process to monitor and evaluate the effectiveness of new and existing technology should be introduced.
The attached policy provides a state wide framework for the introduction of high-cost health technologies into clinical practice.
The scope of this state wide policy will be limited to technologies that are expected to cost more than $1 million annually or $1 million in capital costs. AHS will maintain local policies to address health technologies that fall under this threshold.
Submissions for consideration by WAPACT must be endorsed by the relevant Chief Executive Officer within the AHS. Submissions are thence reviewed by the WAPACT committee and referred to the Operations Review Committee for endorsement.
Enquiries and submissions may be directed to:
Office of the Chief Medical Officer
Level 1, 1 Centro Avenue
Subiaco WA 6008
Mr Kim Snowball
This circular last updated: Monday, 17 May 2010 at 1:28pm